VOYA Investment Management
APGE icon

VOYA Investment Management’s Apogee Therapeutics APGE Stock Holding History

VOYA Investment Management’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Sell
8,555
-19,823
-70% -$1.79M ﹤0.01% 1455
2026
Q1 		$2.39M Buy
28,378
+9,886
+53% +$718K ﹤0.01% 1107
2025
Q4 		$1.4M Buy
18,492
+9,118
+97% +$574K ﹤0.01% 1364
2025
Q3 		$372K Sell
9,374
-3,071
-25% -$117K ﹤0.01% 1900
2025
Q2 		$540K Sell
12,445
-8,982
-42% -$342K ﹤0.01% 1856
2025
Q1 		$801K Sell
21,427
-24,533
-53% -$949K ﹤0.01% 1666
2024
Q4 		$2.08M Sell
45,960
-10,557
-19% -$538K ﹤0.01% 1279
2024
Q3 		$3.32M Buy
56,517
+30,957
+121% +$1.48M ﹤0.01% 1165
2024
Q2 		$1.01M Buy
25,560
+12,227
+92% +$593K ﹤0.01% 1626
2024
Q1 		$886K Buy
13,333
+5,180
+64% +$226K ﹤0.01% 1694
2023
Q4 		$228K Buy
+8,153
New +$163K ﹤0.01% 2515

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

VOYA Investment Management's APGE Position: Q2 2026 in Review

VOYA Investment Management reduced its Apogee Therapeutics (APGE) stake by 70% in Q2 2026, selling an estimated $1.79M and leaving 8,555 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1455.

VOYA Investment Management first reported a position in APGE in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.32M in Q3 2024. 288 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • VOYA Investment Management held 8,555 shares of Apogee Therapeutics worth $1.14M as of Q2 2026.
  • VOYA Investment Management sold 19,823 Apogee Therapeutics shares in Q2 2026, an estimated $1.79M.
  • Apogee Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1455 holding.
  • VOYA Investment Management first reported a position in Apogee Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • VOYA Investment Management's Apogee Therapeutics position peaked at $3.32M in Q3 2024.
  • 288 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.